Heidari Parisa, Blayney Sarah, Butler Jarrhett, Hitomi Emi, Luby Marie, Leigh Richard
National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, United States.
Front Neurol. 2020 Dec 8;11:582994. doi: 10.3389/fneur.2020.582994. eCollection 2020.
Penumbral brain tissue identified with multimodal imaging can be salvaged with reperfusion in an extended time window. The risk of severe hemorrhagic complications after reperfusion therapy increases with worsening disruption of the blood-brain barrier (BBB). The relationship between penumbral tissue and BBB disruption has not been previously studied. Stroke patients presenting in an extended time window without a large vessel occlusion who underwent diffusion-perfusion MRI within 24 h of last-seen-normal were included. The volume of penumbral tissue was calculated using mismatch on MRI. Mean permeability derangement (MPD) of the BBB was measured within the ischemic lesion. A target profile (TP) for treatment was defined based on the EXTEND trial. 222 patients were included with a median age of 73 and 55% women. The median NIHSS was 6, the mean core volume was 14 ml, the mean ischemic volume was 47 mL and the mean mismatch volume was 33 mL. Higher MPD was significantly associated with less mismatch volume ( = 0.001). A target profile was associated with lower MPD (OR 0.97; CI 0.96:0.99; < 0.001). Of the 105 patients who had a TP, 31 (30%) had a MPD > 20% suggesting an increased risk of hemorrhage. Thus, 33% (74/222) of patients had a favorable profile for benefit and safety. Patients presenting in an extended time window with a favorable penumbral profile for treatment have less severe BBB disruption. Up to a third of patients who currently go untreated could be considered for enrollment in a clinical trial of thrombolysis in an extended time window.
通过多模态成像识别出的半暗带脑组织可在延长的时间窗内通过再灌注得以挽救。再灌注治疗后严重出血并发症的风险会随着血脑屏障(BBB)破坏的加重而增加。此前尚未研究过半暗带组织与血脑屏障破坏之间的关系。纳入了在最后一次正常状态后24小时内接受弥散灌注磁共振成像、处于延长时间窗且无大血管闭塞的卒中患者。使用磁共振成像上的不匹配来计算半暗带组织的体积。在缺血性病变内测量血脑屏障的平均通透性紊乱(MPD)。基于EXTEND试验定义了治疗的目标特征(TP)。纳入了222例患者,中位年龄为73岁,女性占55%。美国国立卫生研究院卒中量表(NIHSS)的中位值为6,平均梗死核心体积为14毫升,平均缺血体积为47毫升,平均不匹配体积为33毫升。较高的MPD与较小的不匹配体积显著相关(P = 0.001)。目标特征与较低的MPD相关(比值比0.97;可信区间0.96:0.99;P < 0.001)。在105例具有目标特征的患者中,31例(30%)的MPD > 20%,提示出血风险增加。因此,33%(74/222)的患者具有获益和安全的良好特征。在延长时间窗内表现出具有良好半暗带特征以进行治疗的患者,其血脑屏障破坏较轻。目前未接受治疗的患者中,高达三分之一可考虑纳入延长时间窗内溶栓的临床试验。